Ref-1 and Transcriptional Control of Endothelial Apoptosis
Nanping Wang, Michael B. Stemerman V ascular endothelium, when unperturbed, provides a surface to the blood vessel, which is passive to the development of thrombosis, and potentially adherent blood cells. This characteristic is the quintessence of vascular homeostasis. 1 However, endothelial cells (ECs) can undergo apoptosis in vitro in response to a variety of pathophysiological conditions including hypoxia, proinflammatory cytokines, bacterial endotoxins, and atherogenic risk factors such as homocysteine and lipoproteins (reviewed in Stefanec 2 and Dimmeler and Zeiher 3 ). These cellular perturbations have in common the generation of intracellular reactive oxygen intermediates, referred to as oxidative stress. ECs respond to these adverse conditions by altering their intracellular reduction/oxidization (redox) state and making their ultimate decision between adaptation (survival) and apoptosis (see Figure) . Understanding the precise mechanisms controlling such a process is an important component to our knowledge of cardiovascular diseases. In this issue of Circulation Research, Hall et al 4 provide novel evidence for a critical role of Ref-1, a redox-sensitive regulator, in affecting EC apoptosis.
Ref-1 was cloned as Redox factor, also known as apurinic (apyrimidinic) endonuclease (APE). 5 As a ubiquitously expressed multifunctional 36-kDa protein, Ref-1 is involved in the repair of DNA damage as well as in the transcriptional regulation of genes. Its 5ЈAP-endonuclease functions in base excision repair, and its 3Ј-diesterase activity removes phosphoglycolate residues from DNA damaged by genotoxic stresses. In addition, Ref-1 is also important for the activation of transcription factors, such as activator protein-1 (AP-1), 6, 7 nuclear factor-B (NF-B), 8 p53, 9,10 and hypoxia-inducible factor-1␣ (HIF-1␣). 11 Activation of transcription factors, which occurs via a redox-based mechanism, pertains to its 14 Numerous agents are categorized as having pro-or anti-EC apoptotic properties. What remains as inconclusive and perhaps controversial are the roles of specific transcription factors controlling EC response to these various perturbations. Transcription factor NF-B has, for years, been recognized as a central mediator of gene expression induced by proinflammatory cytokines and pathogens. It is thought to play a pivotal role in cardiovascular diseases including atherosclerosis (see review by Collins and Cybulsky 15 ). Activation of NF-B has been linked to apoptosis, with the factor playing either an antiapoptotic or proapoptotic role, depending on the cell type. Activation of NF-B is essential to protect TNF-␣-induced apoptosis, 16 which appears to be a common mechanism in many cell types. Although how NF-B protects against apoptosis is far from established, it is believed that a major mechanism by which the transcription factor inhibits cell death is to induce the expression of antiapoptotic genes whose products, in turn, provide protection to the cells under adverse conditions. A number of such protective genes that are induced by NF-B have been identified, including inhibitors of apoptosis (IAPs), TNFreceptor-associated factor-1 and -2 (TRAF-1 and TRAF-2), Bcl-2-like factors and A20, a zinc-finger protein that was originally identified as a TNF-inducible gene in ECs. 17 Although NF-B protects ECs from TNF-␣-induced apoptosis, this survival pathway seems to provide little protection against some other apoptotic stimuli such as lipopolysaccharide (LPS), interleukin-1␤, 18 and hypoxia, despite the fact that NF-B is also activated in these scenarios. 18, 19 In addition, certain endothelial survival factors such as Bcl-2, Bcl-X L , 20 and A20, which although suppressing NF-B, can override cellular apoptotic signaling and make NF-B dispensable in EC protection. 21 Because NF-B is a key transcription factor governing a variety of proinflammatory genes including chemokines and adhesion molecules, an NF-B-independent antiapoptotic pathway can protect endothelial integrity without converting the endothelium to a proinflammatory state. Such a mechanism is desirable for therapeutic intervention for many clinical conditions such as reperfusion injury and xenotransplantation. 17 In the present study, Ref-1 rescues ECs from apoptosis via both an NF-B-dependent and -independent mechanism, depending on whether it is triggered by TNF-␣ or by hypoxia. 4 This result reinforces the concept that transcriptional mechanisms regulating EC responses are context-specific.
AP-1 is also a transcription factor regulated by Ref-1 during redox change. AP-1 complexes are composed of various dimers between Jun (c-Jun, JunB, and JunD) and Fos (c-Fos, Fra-1, and Fra-2). 22 Mounting evidence has implied that activation of AP-1 is also associated with an apoptotic response in ECs. Many EC-perturbing agents, such as inflammatory cytokines, LPS, reactive oxygen, and oxidized LDL (oxLDL) induce EC apoptosis as well as c-jun expression. 23 Sustained activation of c-Jun N-terminal kinase (JNK), an immediate c-Jun-activating molecule, induces EC apoptosis. 24 More direct evidence pointing to a proapoptotic role for c-Jun originates from the observation that overexpression of c-Jun in ECs triggers marked apoptosis. However, an N-terminal truncate of c-Jun, missing the transactivation domain, not only loses its proapoptotic property but also provides protection against hydrogen peroxide-induced EC death. 23 A recent report demonstrated the involvement of JNK-c-Jun pathway in oxLDL-induced apoptosis in human coronary artery ECs. 25 What appears to be more paradoxical is that Ref-1 is also known as a potent activator for the tumor suppressor p53, which, when activated in cells, can induce either cell cycle arrest or apoptosis. The p53 is activated in response to genotoxic stresses and is associated with hypoxia-induced EC death. 26 Gaiddon et al 9 recently showed that Ref-1 enhances the proapoptotic functions of p53 in a transformed cell line. It thus seems to be in apparent contradiction that in the present study ECs were prevented from undergoing apoptosis by overexpression of Ref-1, which, on the other hand, may activate p53. However, it should be pointed out that, in the study of Gaiddon et al, Ref-1 increased the ability of p53 to induce apoptosis only when exogenous p53 and Ref-1 were both overexpressed by cotransfection. Thus, it is unclear whether Ref-1 activation of endogenous p53 is to induce apoptosis or, alternatively, to arrest cell cycle. In fact, laminar shear stress, known to promote EC survival, can cause sustained activation of p53 and endothelial growth arrest. 27 Given that Ref-1 possesses dual functions as transcriptional regulator and DNA repair enzyme, it is rational to speculate that these two domains of Ref-1, although they can function independently, may act in concert to protect cells from oxidative damage: one activates p53 to ensure efficient cell-cycle arrest for the other to fix the DNA damage. 28 Although the consequences of activating these transcription factors remain poorly understood, it can be hypothesized that Ref-1 may play a pivotal role in integrating the transcriptional response and, thus, control EC fate under specific oxidative conditions. However, an important caveat must be considered regarding the pathogenetic importance of EC apoptosis. Most reports studying EC programmed cell death have examined the process in cell culture. Although a few studies have shown in situ detection of EC apoptosis in microvessels 29 and transplant coronary artery disease, 30 it is yet uncertain as to its importance in major circulatory disorders such as atherosclerosis. Until such in vivo studies are carried out, the role for EC apoptosis in vascular diseases remains speculative. 
